Request for Covid-19 Impact Assessment of this Report
The United States Polio (Poliomyelitis) Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Polio (Poliomyelitis) Vaccines market, reaching US$ million by the year 2028. As for the Europe Polio (Poliomyelitis) Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Polio (Poliomyelitis) Vaccines players cover Sanofi, GSK, Bibcol, and Serum Institute, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Polio (Poliomyelitis) Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Polio (Poliomyelitis) Vaccines Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Polio (Poliomyelitis) Vaccines by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Polio (Poliomyelitis) Vaccines by Country/Region, 2017, 2022 & 2028
2.2 Polio (Poliomyelitis) Vaccines Segment by Type
2.2.1 Inactivated Polio Vaccine (IPV)
2.2.2 Oral Polio Vaccine (OPV)
2.3 Polio (Poliomyelitis) Vaccines Sales by Type
2.3.1 Global Polio (Poliomyelitis) Vaccines Sales Market Share by Type (2017-2022)
2.3.2 Global Polio (Poliomyelitis) Vaccines Revenue and Market Share by Type (2017-2022)
2.3.3 Global Polio (Poliomyelitis) Vaccines Sale Price by Type (2017-2022)
2.4 Polio (Poliomyelitis) Vaccines Segment by Application
2.4.1 Research & Academic Laboratories
2.4.2 Pharmaceutical & Biotechnology Companies
2.4.3 Others
2.5 Polio (Poliomyelitis) Vaccines Sales by Application
2.5.1 Global Polio (Poliomyelitis) Vaccines Sale Market Share by Application (2017-2022)
2.5.2 Global Polio (Poliomyelitis) Vaccines Revenue and Market Share by Application (2017-2022)
2.5.3 Global Polio (Poliomyelitis) Vaccines Sale Price by Application (2017-2022)
3 Global Polio (Poliomyelitis) Vaccines by Company
3.1 Global Polio (Poliomyelitis) Vaccines Breakdown Data by Company
3.1.1 Global Polio (Poliomyelitis) Vaccines Annual Sales by Company (2020-2022)
3.1.2 Global Polio (Poliomyelitis) Vaccines Sales Market Share by Company (2020-2022)
3.2 Global Polio (Poliomyelitis) Vaccines Annual Revenue by Company (2020-2022)
3.2.1 Global Polio (Poliomyelitis) Vaccines Revenue by Company (2020-2022)
3.2.2 Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Company (2020-2022)
3.3 Global Polio (Poliomyelitis) Vaccines Sale Price by Company
3.4 Key Manufacturers Polio (Poliomyelitis) Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Polio (Poliomyelitis) Vaccines Product Location Distribution
3.4.2 Players Polio (Poliomyelitis) Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Polio (Poliomyelitis) Vaccines by Geographic Region
4.1 World Historic Polio (Poliomyelitis) Vaccines Market Size by Geographic Region (2017-2022)
4.1.1 Global Polio (Poliomyelitis) Vaccines Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Polio (Poliomyelitis) Vaccines Annual Revenue by Geographic Region
4.2 World Historic Polio (Poliomyelitis) Vaccines Market Size by Country/Region (2017-2022)
4.2.1 Global Polio (Poliomyelitis) Vaccines Annual Sales by Country/Region (2017-2022)
4.2.2 Global Polio (Poliomyelitis) Vaccines Annual Revenue by Country/Region
4.3 Americas Polio (Poliomyelitis) Vaccines Sales Growth
4.4 APAC Polio (Poliomyelitis) Vaccines Sales Growth
4.5 Europe Polio (Poliomyelitis) Vaccines Sales Growth
4.6 Middle East & Africa Polio (Poliomyelitis) Vaccines Sales Growth
5 Americas
5.1 Americas Polio (Poliomyelitis) Vaccines Sales by Country
5.1.1 Americas Polio (Poliomyelitis) Vaccines Sales by Country (2017-2022)
5.1.2 Americas Polio (Poliomyelitis) Vaccines Revenue by Country (2017-2022)
5.2 Americas Polio (Poliomyelitis) Vaccines Sales by Type
5.3 Americas Polio (Poliomyelitis) Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Polio (Poliomyelitis) Vaccines Sales by Region
6.1.1 APAC Polio (Poliomyelitis) Vaccines Sales by Region (2017-2022)
6.1.2 APAC Polio (Poliomyelitis) Vaccines Revenue by Region (2017-2022)
6.2 APAC Polio (Poliomyelitis) Vaccines Sales by Type
6.3 APAC Polio (Poliomyelitis) Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Polio (Poliomyelitis) Vaccines by Country
7.1.1 Europe Polio (Poliomyelitis) Vaccines Sales by Country (2017-2022)
7.1.2 Europe Polio (Poliomyelitis) Vaccines Revenue by Country (2017-2022)
7.2 Europe Polio (Poliomyelitis) Vaccines Sales by Type
7.3 Europe Polio (Poliomyelitis) Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Polio (Poliomyelitis) Vaccines by Country
8.1.1 Middle East & Africa Polio (Poliomyelitis) Vaccines Sales by Country (2017-2022)
8.1.2 Middle East & Africa Polio (Poliomyelitis) Vaccines Revenue by Country (2017-2022)
8.2 Middle East & Africa Polio (Poliomyelitis) Vaccines Sales by Type
8.3 Middle East & Africa Polio (Poliomyelitis) Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Polio (Poliomyelitis) Vaccines
10.3 Manufacturing Process Analysis of Polio (Poliomyelitis) Vaccines
10.4 Industry Chain Structure of Polio (Poliomyelitis) Vaccines
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Polio (Poliomyelitis) Vaccines Distributors
11.3 Polio (Poliomyelitis) Vaccines Customer
12 World Forecast Review for Polio (Poliomyelitis) Vaccines by Geographic Region
12.1 Global Polio (Poliomyelitis) Vaccines Market Size Forecast by Region
12.1.1 Global Polio (Poliomyelitis) Vaccines Forecast by Region (2023-2028)
12.1.2 Global Polio (Poliomyelitis) Vaccines Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Polio (Poliomyelitis) Vaccines Forecast by Type
12.7 Global Polio (Poliomyelitis) Vaccines Forecast by Application
13 Key Players Analysis
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Polio (Poliomyelitis) Vaccines Product Offered
13.1.3 Sanofi Polio (Poliomyelitis) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Polio (Poliomyelitis) Vaccines Product Offered
13.2.3 GSK Polio (Poliomyelitis) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Bibcol
13.3.1 Bibcol Company Information
13.3.2 Bibcol Polio (Poliomyelitis) Vaccines Product Offered
13.3.3 Bibcol Polio (Poliomyelitis) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Bibcol Main Business Overview
13.3.5 Bibcol Latest Developments
13.4 Serum Institute
13.4.1 Serum Institute Company Information
13.4.2 Serum Institute Polio (Poliomyelitis) Vaccines Product Offered
13.4.3 Serum Institute Polio (Poliomyelitis) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Serum Institute Main Business Overview
13.4.5 Serum Institute Latest Developments
13.5 Tiantan Biological
13.5.1 Tiantan Biological Company Information
13.5.2 Tiantan Biological Polio (Poliomyelitis) Vaccines Product Offered
13.5.3 Tiantan Biological Polio (Poliomyelitis) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Tiantan Biological Main Business Overview
13.5.5 Tiantan Biological Latest Developments
13.6 IMBCA
13.6.1 IMBCA Company Information
13.6.2 IMBCA Polio (Poliomyelitis) Vaccines Product Offered
13.6.3 IMBCA Polio (Poliomyelitis) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 IMBCA Main Business Overview
13.6.5 IMBCA Latest Developments
13.7 Panacea Biotec Ltd
13.7.1 Panacea Biotec Ltd Company Information
13.7.2 Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Product Offered
13.7.3 Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Panacea Biotec Ltd Main Business Overview
13.7.5 Panacea Biotec Ltd Latest Developments
13.8 Bio-Med
13.8.1 Bio-Med Company Information
13.8.2 Bio-Med Polio (Poliomyelitis) Vaccines Product Offered
13.8.3 Bio-Med Polio (Poliomyelitis) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Bio-Med Main Business Overview
13.8.5 Bio-Med Latest Developments
13.9 Halfkin Bio-Pharmaceuticals
13.9.1 Halfkin Bio-Pharmaceuticals Company Information
13.9.2 Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Product Offered
13.9.3 Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Halfkin Bio-Pharmaceuticals Main Business Overview
13.9.5 Halfkin Bio-Pharmaceuticals Latest Developments
14 Research Findings and Conclusion
Table 1. Polio (Poliomyelitis) Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Polio (Poliomyelitis) Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Inactivated Polio Vaccine (IPV)
Table 4. Major Players of Oral Polio Vaccine (OPV)
Table 5. Global Polio (Poliomyelitis) Vaccines Sales by Type (2017-2022) & (K Units)
Table 6. Global Polio (Poliomyelitis) Vaccines Sales Market Share by Type (2017-2022)
Table 7. Global Polio (Poliomyelitis) Vaccines Revenue by Type (2017-2022) & ($ million)
Table 8. Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Type (2017-2022)
Table 9. Global Polio (Poliomyelitis) Vaccines Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Polio (Poliomyelitis) Vaccines Sales by Application (2017-2022) & (K Units)
Table 11. Global Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2017-2022)
Table 12. Global Polio (Poliomyelitis) Vaccines Revenue by Application (2017-2022)
Table 13. Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Application (2017-2022)
Table 14. Global Polio (Poliomyelitis) Vaccines Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Polio (Poliomyelitis) Vaccines Sales by Company (2020-2022) & (K Units)
Table 16. Global Polio (Poliomyelitis) Vaccines Sales Market Share by Company (2020-2022)
Table 17. Global Polio (Poliomyelitis) Vaccines Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Company (2020-2022)
Table 19. Global Polio (Poliomyelitis) Vaccines Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Polio (Poliomyelitis) Vaccines Producing Area Distribution and Sales Area
Table 21. Players Polio (Poliomyelitis) Vaccines Products Offered
Table 22. Polio (Poliomyelitis) Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Polio (Poliomyelitis) Vaccines Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Polio (Poliomyelitis) Vaccines Sales Market Share Geographic Region (2017-2022)
Table 27. Global Polio (Poliomyelitis) Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Polio (Poliomyelitis) Vaccines Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Polio (Poliomyelitis) Vaccines Sales Market Share by Country/Region (2017-2022)
Table 31. Global Polio (Poliomyelitis) Vaccines Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Polio (Poliomyelitis) Vaccines Sales by Country (2017-2022) & (K Units)
Table 34. Americas Polio (Poliomyelitis) Vaccines Sales Market Share by Country (2017-2022)
Table 35. Americas Polio (Poliomyelitis) Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Polio (Poliomyelitis) Vaccines Revenue Market Share by Country (2017-2022)
Table 37. Americas Polio (Poliomyelitis) Vaccines Sales by Type (2017-2022) & (K Units)
Table 38. Americas Polio (Poliomyelitis) Vaccines Sales Market Share by Type (2017-2022)
Table 39. Americas Polio (Poliomyelitis) Vaccines Sales by Application (2017-2022) & (K Units)
Table 40. Americas Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2017-2022)
Table 41. APAC Polio (Poliomyelitis) Vaccines Sales by Region (2017-2022) & (K Units)
Table 42. APAC Polio (Poliomyelitis) Vaccines Sales Market Share by Region (2017-2022)
Table 43. APAC Polio (Poliomyelitis) Vaccines Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Polio (Poliomyelitis) Vaccines Revenue Market Share by Region (2017-2022)
Table 45. APAC Polio (Poliomyelitis) Vaccines Sales by Type (2017-2022) & (K Units)
Table 46. APAC Polio (Poliomyelitis) Vaccines Sales Market Share by Type (2017-2022)
Table 47. APAC Polio (Poliomyelitis) Vaccines Sales by Application (2017-2022) & (K Units)
Table 48. APAC Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2017-2022)
Table 49. Europe Polio (Poliomyelitis) Vaccines Sales by Country (2017-2022) & (K Units)
Table 50. Europe Polio (Poliomyelitis) Vaccines Sales Market Share by Country (2017-2022)
Table 51. Europe Polio (Poliomyelitis) Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Polio (Poliomyelitis) Vaccines Revenue Market Share by Country (2017-2022)
Table 53. Europe Polio (Poliomyelitis) Vaccines Sales by Type (2017-2022) & (K Units)
Table 54. Europe Polio (Poliomyelitis) Vaccines Sales Market Share by Type (2017-2022)
Table 55. Europe Polio (Poliomyelitis) Vaccines Sales by Application (2017-2022) & (K Units)
Table 56. Europe Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Polio (Poliomyelitis) Vaccines Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Polio (Poliomyelitis) Vaccines Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Polio (Poliomyelitis) Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Polio (Poliomyelitis) Vaccines Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Polio (Poliomyelitis) Vaccines Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Polio (Poliomyelitis) Vaccines Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Polio (Poliomyelitis) Vaccines Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Polio (Poliomyelitis) Vaccines
Table 66. Key Market Challenges & Risks of Polio (Poliomyelitis) Vaccines
Table 67. Key Industry Trends of Polio (Poliomyelitis) Vaccines
Table 68. Polio (Poliomyelitis) Vaccines Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Polio (Poliomyelitis) Vaccines Distributors List
Table 71. Polio (Poliomyelitis) Vaccines Customer List
Table 72. Global Polio (Poliomyelitis) Vaccines Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Polio (Poliomyelitis) Vaccines Sales Market Forecast by Region
Table 74. Global Polio (Poliomyelitis) Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Polio (Poliomyelitis) Vaccines Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Polio (Poliomyelitis) Vaccines Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Polio (Poliomyelitis) Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Polio (Poliomyelitis) Vaccines Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Polio (Poliomyelitis) Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Polio (Poliomyelitis) Vaccines Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Polio (Poliomyelitis) Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Polio (Poliomyelitis) Vaccines Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Polio (Poliomyelitis) Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Polio (Poliomyelitis) Vaccines Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Polio (Poliomyelitis) Vaccines Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Polio (Poliomyelitis) Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Polio (Poliomyelitis) Vaccines Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Polio (Poliomyelitis) Vaccines Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Polio (Poliomyelitis) Vaccines Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Polio (Poliomyelitis) Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Polio (Poliomyelitis) Vaccines Revenue Market Share Forecast by Application (2023-2028)
Table 92. Sanofi Basic Information, Polio (Poliomyelitis) Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 93. Sanofi Polio (Poliomyelitis) Vaccines Product Offered
Table 94. Sanofi Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Sanofi Main Business
Table 96. Sanofi Latest Developments
Table 97. GSK Basic Information, Polio (Poliomyelitis) Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 98. GSK Polio (Poliomyelitis) Vaccines Product Offered
Table 99. GSK Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. GSK Main Business
Table 101. GSK Latest Developments
Table 102. Bibcol Basic Information, Polio (Poliomyelitis) Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 103. Bibcol Polio (Poliomyelitis) Vaccines Product Offered
Table 104. Bibcol Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Bibcol Main Business
Table 106. Bibcol Latest Developments
Table 107. Serum Institute Basic Information, Polio (Poliomyelitis) Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 108. Serum Institute Polio (Poliomyelitis) Vaccines Product Offered
Table 109. Serum Institute Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Serum Institute Main Business
Table 111. Serum Institute Latest Developments
Table 112. Tiantan Biological Basic Information, Polio (Poliomyelitis) Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 113. Tiantan Biological Polio (Poliomyelitis) Vaccines Product Offered
Table 114. Tiantan Biological Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. Tiantan Biological Main Business
Table 116. Tiantan Biological Latest Developments
Table 117. IMBCA Basic Information, Polio (Poliomyelitis) Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 118. IMBCA Polio (Poliomyelitis) Vaccines Product Offered
Table 119. IMBCA Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. IMBCA Main Business
Table 121. IMBCA Latest Developments
Table 122. Panacea Biotec Ltd Basic Information, Polio (Poliomyelitis) Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 123. Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Product Offered
Table 124. Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. Panacea Biotec Ltd Main Business
Table 126. Panacea Biotec Ltd Latest Developments
Table 127. Bio-Med Basic Information, Polio (Poliomyelitis) Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 128. Bio-Med Polio (Poliomyelitis) Vaccines Product Offered
Table 129. Bio-Med Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 130. Bio-Med Main Business
Table 131. Bio-Med Latest Developments
Table 132. Halfkin Bio-Pharmaceuticals Basic Information, Polio (Poliomyelitis) Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 133. Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Product Offered
Table 134. Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 135. Halfkin Bio-Pharmaceuticals Main Business
Table 136. Halfkin Bio-Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Polio (Poliomyelitis) Vaccines
Figure 2. Polio (Poliomyelitis) Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Polio (Poliomyelitis) Vaccines Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Polio (Poliomyelitis) Vaccines Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Polio (Poliomyelitis) Vaccines Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Inactivated Polio Vaccine (IPV)
Figure 10. Product Picture of Oral Polio Vaccine (OPV)
Figure 11. Global Polio (Poliomyelitis) Vaccines Sales Market Share by Type in 2021
Figure 12. Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Type (2017-2022)
Figure 13. Polio (Poliomyelitis) Vaccines Consumed in Research & Academic Laboratories
Figure 14. Global Polio (Poliomyelitis) Vaccines Market: Research & Academic Laboratories (2017-2022) & (K Units)
Figure 15. Polio (Poliomyelitis) Vaccines Consumed in Pharmaceutical & Biotechnology Companies
Figure 16. Global Polio (Poliomyelitis) Vaccines Market: Pharmaceutical & Biotechnology Companies (2017-2022) & (K Units)
Figure 17. Polio (Poliomyelitis) Vaccines Consumed in Others
Figure 18. Global Polio (Poliomyelitis) Vaccines Market: Others (2017-2022) & (K Units)
Figure 19. Global Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2017-2022)
Figure 20. Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Application in 2021
Figure 21. Polio (Poliomyelitis) Vaccines Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Company in 2021
Figure 23. Global Polio (Poliomyelitis) Vaccines Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Geographic Region in 2021
Figure 25. Global Polio (Poliomyelitis) Vaccines Sales Market Share by Region (2017-2022)
Figure 26. Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Country/Region in 2021
Figure 27. Americas Polio (Poliomyelitis) Vaccines Sales 2017-2022 (K Units)
Figure 28. Americas Polio (Poliomyelitis) Vaccines Revenue 2017-2022 ($ Millions)
Figure 29. APAC Polio (Poliomyelitis) Vaccines Sales 2017-2022 (K Units)
Figure 30. APAC Polio (Poliomyelitis) Vaccines Revenue 2017-2022 ($ Millions)
Figure 31. Europe Polio (Poliomyelitis) Vaccines Sales 2017-2022 (K Units)
Figure 32. Europe Polio (Poliomyelitis) Vaccines Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Polio (Poliomyelitis) Vaccines Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Polio (Poliomyelitis) Vaccines Revenue 2017-2022 ($ Millions)
Figure 35. Americas Polio (Poliomyelitis) Vaccines Sales Market Share by Country in 2021
Figure 36. Americas Polio (Poliomyelitis) Vaccines Revenue Market Share by Country in 2021
Figure 37. United States Polio (Poliomyelitis) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Polio (Poliomyelitis) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Polio (Poliomyelitis) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Polio (Poliomyelitis) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Polio (Poliomyelitis) Vaccines Sales Market Share by Region in 2021
Figure 42. APAC Polio (Poliomyelitis) Vaccines Revenue Market Share by Regions in 2021
Figure 43. China Polio (Poliomyelitis) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Polio (Poliomyelitis) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Polio (Poliomyelitis) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Polio (Poliomyelitis) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Polio (Poliomyelitis) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Polio (Poliomyelitis) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Polio (Poliomyelitis) Vaccines Sales Market Share by Country in 2021
Figure 50. Europe Polio (Poliomyelitis) Vaccines Revenue Market Share by Country in 2021
Figure 51. Germany Polio (Poliomyelitis) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Polio (Poliomyelitis) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Polio (Poliomyelitis) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Polio (Poliomyelitis) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Polio (Poliomyelitis) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Polio (Poliomyelitis) Vaccines Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Polio (Poliomyelitis) Vaccines Revenue Market Share by Country in 2021
Figure 58. Egypt Polio (Poliomyelitis) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Polio (Poliomyelitis) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Polio (Poliomyelitis) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Polio (Poliomyelitis) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Polio (Poliomyelitis) Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Polio (Poliomyelitis) Vaccines in 2021
Figure 64. Manufacturing Process Analysis of Polio (Poliomyelitis) Vaccines
Figure 65. Industry Chain Structure of Polio (Poliomyelitis) Vaccines
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...